Applied Materials, Inc. (AMAT)
Verdict history · AMAT
Every call Verdix has made on AMAT.
While a verdict holds, its return keeps accumulating from the day the call was made — it resets only when the verdict itself changes.
Click any date below to read that write-up
Three months ago the panel was unanimous in caution: zero of five voices saw a reason to buy at $507, and the Disruptive-Innovation Seeker's presence kept the debate anchored to how much of the AI story was already priced in. Now the Scuttlebutt Growth Investor replaces the Innovation Seeker, and three bulls argue the $15 pullback has cracked open a window — but the two holdouts pull in opposite directions, one rejecting the price and the other rejecting the business itself, so the verdict upgrades only from WAIT to BALANCED rather than reaching BUY.
See methodology for how verdicts are produced. Full track record →
The panel’s split verdict on AMAT — and where they disagree.
The case for and against roughly balance — no clear edge at today's price.
NASDAQ · Information Technology / Semiconductor Equipment · 2026-08-22 · analysis, not advice
Key levels and fundamentals figures are sourced from public market data and filings. All panel verdicts, archetype reasoning, and synthesis are AI-generated analysis.
Verdict
BalancedMEDIUM confidence
Why
Applied Materials divides the panel: three voices see a high-quality AI-driven growth story at a reasonable PEG, while two holdouts — one objecting on price, one on the business cycle — keep the verdict at BALANCED. The next move hinges on whether the stock reclaims $516 or loses $484 on a weekly closing basis.Level to watch
Key support 490.45−0.4% from 492.32
Next catalyst
Trigger to confirm the correction is over: A weekly close above $516.12 (the 38.2% Fibonacci retracement of the $154-to-$740 rally) would signal momentum re-accelerating and flip the verdict to BUY.The panel's take
Verdict: BALANCED · Conviction: MEDIUM · Last price: 492.32 · Changed from WAIT
Panel: 3 Bullish · 1 Neutral · 1 Bearish → BALANCED
What changed since 2026-08-15:
- Price: 507.18 → 492.32 (-2.93%)
- Panel: 0 of 5 → 3 of 5 now Bullish — composition also changed: added The Scuttlebutt Growth Investor; removed The Disruptive-Innovation Seeker
- Trigger: A weekly close below $484.28 (monthly 38.2% Fibonacci) breaks the first major Fibonacci support on the dominant timeframe and flips the verdict to SELL; a weekly close above $516.12 (weekly 38.2% Fibonacci of the $154→$740 rally) confirms the correction is over and flips it to BUY. Whichever level is breached first on a closing basis decides the next direction.
- Verdict: WAIT → BALANCED
Three months ago the panel was unanimous in caution: zero of five voices saw a reason to buy at $507, and the Disruptive-Innovation Seeker's presence kept the debate anchored to how much of the AI story was already priced in. Now the Scuttlebutt Growth Investor replaces the Innovation Seeker, and three bulls argue the $15 pullback has cracked open a window — but the two holdouts pull in opposite directions, one rejecting the price and the other rejecting the business itself, so the verdict upgrades only from WAIT to BALANCED rather than reaching BUY.
Three of five voices — The GARP Operator, The Intrinsic-Value Modeler, and The Scuttlebutt Growth Investor — are bullish on the business: the AI-driven equipment cycle is accelerating, the moat is wide, and a PEG of 0.94 says growth is underpriced. But the verdict lands at BALANCED rather than BUY because the two holdouts pull in opposite directions with force. The Moat Compounder (Neutral) calls AMAT a wonderful business but sees no margin of safety — the 3.6% earnings yield sits below the 4.7% risk-free rate, and he'd need $350–400 to buy. The Forensic Skeptic (Bearish) goes further: he sees a cyclical peak dressed as a secular story, with insider selling and superinvestor trimming as confirming signals that the smart money is exiting. The three bulls keep SELL off the table, but the two cautious voices — one objecting on price, the other on the business itself — deny BUY the majority it would need.
Key levels
Key levels · AMAT
USD · as of 2026-08-22Analyst consensus target 641.03 USD · range 358–900
Key support & resistance and analyst consensus — educational analysis, not advice. These are not entry or exit prices. Trading involves risk of loss.
Key support at $490.45 is the weekly EMA20 — price is testing it now after a 33.4% pullback from the $739.67 all-time high, and it has held so far. Just below, $484.28 is the monthly 38.2% Fibonacci retracement of the entire $71→$740 rally; it has not yet been tested and a weekly close beneath it would be the first serious technical evidence that the Stage 2 uptrend is faltering. The $447.07 level (weekly 50% Fib) and the $395.85–$405.40 confluence zone (weekly EMA50 plus monthly 50% Fib) form deeper structural support where value-oriented voices have indicated they would turn constructive. Key resistance at $516.12 is the weekly 38.2% Fibonacci retracement of the decline — the level the technical scout and The GARP Operator both name as the confirmation that the correction has ended. The analyst consensus target of $641.03 sits roughly 30% above the current price, aligning with the fundamental scout's BUY case but well above where the cautious voices are willing to commit.
What legendary investors think
We ran Applied Materials, Inc. past a panel of 5 legendary investors' frameworks.
The panel · 5 investors
The GARP OperatorGrowth (GARP)🟢 BullishMed
Signal: A PEG ratio of 0.94 on 35% EPS growth with a net-cash balance sheet and management guiding for "another strong growth year in 2027" places AMAT squarely in the undervalued Fast Grower category, with the market effectively pricing that 35% growth rate at zero premium. Conviction: Conviction firms up because three separate pillars — the sub-1.0 PEG, eight-quarter customer order visibility, and a bulletproof balance sheet with 34x interest coverage — reinforce each other without depending on any single assumption.
The Intrinsic-Value ModelerValuation/DCF🟢 BullishMed
Signal: A DCF that bakes in conservative fade assumptions (growth decelerating from 20% to 5% over five years, terminal margin of 33%) still spits out a fair value of $565, suggesting the current $492 price embeds a cushion of roughly 15% even if the AI cycle proves shorter than the bulls hope. Conviction: Confidence stays capped at 65% because the entire valuation hinges on one contested projection: whether revenue growth sustains for three years or five; a deceleration one year sooner would shave $100 or more off the fair value estimate.
The Scuttlebutt Growth InvestorGrowth/Management🟢 BullishMed
Signal: Thirteen of fifteen checklist items check out — including 13 straight quarters of gross margin improvement, clean cash conversion above 110%, and customers supplying eight-quarter demand forecasts — which signals a management team and business model built for sustained, compounding excellence rather than a lucky cyclical upswing. Conviction: The two unscored items are missing data rather than red flags, so conviction rests on an unusually broad base of independently verified strengths rather than a single thesis plank.
The Forensic SkepticContrarian/Forensic🔴 BearishLow
Signal: The stock trades at 15x tangible book and 28x forward earnings while 10 of 15 tracked superinvestors reduced positions in Q2 2026 and insiders sold across 39 transactions in the last 90 days, a pattern that historically accompanies cyclical peaks rather than secular breakouts. Conviction: The bear case carries weight but requires patience: if the eight-quarter forecasts management cites prove accurate, the short thesis could take 18 months to play out, and the 33% decline from the peak may have already absorbed some of the mean-reversion risk.
The Moat CompounderValue/Quality/Moat⚫ NeutralMed
Signal: Applied Materials checks every box for a wonderful business — wide and widening moat, 41% ROE, net cash, 34x interest coverage — but at $492 the forward earnings yield of 3.6% sits below the 4.7% risk-free rate, leaving no margin of safety for a cyclical equipment maker. Conviction: The neutral stance holds firm because the quality of the business and the richness of the price pull in opposite directions with roughly equal force; neither bull nor bear can land a decisive blow until one of those forces gives way.
Each view is one investing framework applied to the stock — a perspective, not advice, and identical for every reader. Signals are the panel's own scale, not a recommendation to act.
Where they agree — and where they clash
Common ground
- All five archetypes recognize AMAT's business quality as exceptional: wide moat, high ROIC/ROE, strong balance sheet, and genuine AI-driven demand tailwinds.
- All five flag insider selling and superinvestor position reductions as a caution signal worth tracking, even if they disagree on how much weight to assign it.
- All five acknowledge the stock is in a correction from its $740 peak, with key Fibonacci levels providing a shared technical framework for the next directional move.
The real debate
- The GARP Operator and Scuttlebutt Growth Investor see a PEG of 0.94 and a 13/15 checklist score as evidence the growth is underpriced, while the Forensic Skeptic sees those same metrics as classic peak-cycle seductions that ignore mean reversion in semiconductor equipment spending.
- The Moat Compounder agrees with the bulls on business quality but sides with the bear on price: a 3.6% earnings yield versus a 4.7% risk-free rate is the reason he stays neutral despite calling AMAT "wonderful."
- The Intrinsic-Value Modeler splits the difference numerically ($565 fair value equals modest upside), but his model's sensitivity to the growth-duration assumption means he is one quarter of deceleration away from joining the cautious camp.
The question it comes down to: Does the AI-driven equipment cycle have at least three more years of above-trend growth, or are the insider sales and superinvestor exits correctly signaling that the current expansion is closer to its end than its beginning?
The bottom line
- Trigger to confirm the correction is over: A weekly close above $516.12 (the 38.2% Fibonacci retracement of the $154-to-$740 rally) would signal momentum re-accelerating and flip the verdict to BUY.
- Trigger to confirm the breakdown: A weekly close below $484.28 (the monthly 38.2% Fibonacci) would break the first major Fibonacci support on the dominant timeframe and flip the verdict to SELL.
- Next catalyst: The Q4 FY2026 report expected in November 2026: another beat-and-raise would validate the eight-quarter visibility thesis; a guidance reduction would vindicate the cyclical-peak argument.
- Risk to monitor: China revenue concentration at 28% of sales means any expansion of export controls could materially reset the growth trajectory and the PEG calculation that anchors the bull case.
contact@verdixhq.com · Published 2026-08-22 · Prices as of 2026-08-22 · Time horizon: 3–12 months · No direct position held in AMAT · AMAT verdict history → · Methodology →
Verdix's panel is made up of AI archetypes that apply the well-documented, publicly known investment frameworks of famous investors. They are AI agents — not the investors themselves. Verdix is not affiliated with, endorsed by, or authorized by any real individual, and the archetypes do not represent any real person's actual views, holdings, or statements. Every verdict is AI-generated.
Verdix provides educational equity research and AI-generated multi-perspective analysis. Nothing here constitutes personalized investment advice or a recommendation to buy or sell any security. Verdicts are uniform across all users and do not consider your individual financial situation, risk tolerance, or objectives. Trading and investing involve substantial risk of loss. Past performance does not predict future results. Consult a licensed financial advisor before making investment decisions.
The panel also debated